Niagen Bioscience, Inc.

NAGE

Financials

10-QQ2 ended 06/30/2608/04/26 10-QQ1 ended 03/31/2605/06/26 10-KFY 202503/04/26 10-QQ3 ended 09/30/2511/04/25 10-QQ2 ended 06/30/2508/06/25

Disclosures

8-KCurrent report08/04/26 8-KCurrent report06/29/26 8-KCurrent report05/06/26 8-KCurrent report03/19/26 8-KCurrent report03/04/26

Prospectuses and Registrations

424B5Prospectus supplement07/10/26 S-3Shelf registration06/29/26 S-8Registration of securities for employees08/08/25 S-8Registration of securities for employees08/08/25 424B3Prospectus11/21/24

Proxies

DEF 14ADefinitive proxy04/29/26 DEFA14AAdditional proxy materials04/29/26 DEF 14ADefinitive proxy04/29/25 DEFA14AAdditional proxy materials04/29/25 DEF 14ADefinitive proxy04/25/24

Ownership

SC 13GBeneficial ownership07/29/26 Form 4Insider transaction07/08/26 Form 4Insider transaction07/08/26 Form 4Insider transaction07/08/26 Form 4Insider transaction06/26/26

Other

EFFECTRequest for effectiveness07/09/26 ARSAnnual report to shareholders04/29/26 ARSAnnual report to shareholders04/29/25 ARSAnnual report to shareholders04/25/24 EFFECTRequest for effectiveness07/05/23